echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > National Health and Safety Commission: Strengthen the management of narcotic drugs and psychotic drugs in medical institutions

    National Health and Safety Commission: Strengthen the management of narcotic drugs and psychotic drugs in medical institutions

    • Last Update: 2020-11-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On September 15th, the State Health and Safety Commission issued a notice on strengthening the management of narcotic drugs and psychotic drugs in medical institutions, aiming to strengthen the management of narcotic drugs and psychotic drugs in the first category of medical institutions (hereinafter referred to as hemp essence drugs), to ensure reasonable clinical needs and to strictly prevent the flow of illegal channels.
    "Notice" based on the current medical institutions, the main problems in the management of hemp essence drugs, put forward seven specific requirements.
    , attaches great importance to the management of hemp essence medicine is China's legal implementation of special management of drugs.
    Hemp essence drugs have obvious two sides, on the one hand, there is a strong role of analgesic sedation, is essential for clinical diagnosis and treatment of drugs, on the other hand, the non-standard continuous use of dependence, addiction, if into illegal channels will cause serious social harm and even illegal crimes.
    Health administrative departments and medical institutions at all levels should attach great importance to the management of the clinical application of hemp essence drugs, carefully comb through the existing hidden loopholes, formulate and improve the management of hemp essence drugs, and at the same time meet clinical needs, prevent the flow of hemp essence drugs from medical institutions into illegal channels.
    , improve the medical institutions of the management system of hemp essence drugs medical institutions are the main body of responsibility for the clinical application management of hemp essence drugs.
    person in charge of a medical institution shall perform the duties of the person in charge of the management of hisxymp drugs in this institution.
    The relevant personnel for the management and use of hemp essence drugs should earnestly study and implement the Regulations of the People's Republic of China on drug administration, the Regulations on the Administration of Narcotic Drugs and Psychotic Drugs, the Prescription Management Measures, the Regulations on the Administration of Narcotic Drugs in Medical Institutions, the Regulations on the Administration of Narcotic Drugs and the Administration of The Administration of The Printing Cards for the Purchase of Psychotic Drugs in the First Class, and so on, so as to clarify the responsibilities of the management departments and personnel in various positions of hemp essence drugs, and comprehensively strengthen the procurement, storage, deployment, use and safety management of hemp essence drugs.
    For departments with large use of hemp essence drugs such as anesthesiology departments and operating rooms, and with more use management links, we should focus on strengthening management, set up a special working group with the head of the department as the first person responsible, and strengthen the daily management of hemp essence drugs.
    through a variety of measures, the formation of the system to standardize the link management, responsibility to promote the implementation of the system management model.
    3. Strengthen the management of all aspects of the whole process of hemp essence drugs health administrative departments at all levels to strengthen the management of the prescribing and use of hemp essence drugs, encourage conditional areas to achieve regional prescription information networking, focusing on the number of prescriptions and frequency of prescriptions of hemp essence drugs, to avoid the same patient in multiple medical institutions, in the same medical institutions outpatient and inpatient repeated access to hemp essence drugs.
    medical institutions should fully implement the requirements of the management of hemp essence drugs, and further strengthen the management of all aspects of the process.
    according to the needs of clinical diagnosis and treatment, the procurement of suitable packaging, specifications of hemp essence drugs, reduce the production of residual liquid.
    emergency pharmacies, inpatient pharmacies, wards, operating rooms, endoscopy rooms and other key departments equipped with the base of leprosy drugs, to use double-lock safes or hemp medicine intelligent deployment cabinet storage, storage area with anti-theft facilities and security monitoring system.
    to strengthen the safety of drugs in the operating room, the installation of video surveillance devices to monitor the collection of drugs and recovery of drugs and other behavior.
    the relevant surveillance video for a period of not less than 180 days in principle.
    the use and recycling management of hemp essence drugs should be done day and day, accounts consistent.
    patients with chronic diseases such as cancer pain who need long-term outpatient use of leprosy drugs shall, through informationization or the establishment of outpatient medical records, record in detail the assessment and prescription of each drug.
    4. To regulate the prescription authority and use of hemp essence drugs management physicians and pharmacists shall, in accordance with the relevant provisions, pass the training and examination of the knowledge and standardized management of the use of hemp essence drugs organized by medical institutions before they can obtain the corresponding prescription rights for hemp essence drugs or the qualification for the deployment of hemp essence drugs.
    medical institutions should further refine and improve the specific operating procedures and specification requirements for the whole process of the use of hemp essence drugs.
    especially for key departments, we should strictly implement the whole two-person operation system, change the current situation of single-person operation of hemp essence drugs by anesthesiologists, the prescription, use and management of hemp essence drugs may not be carried out by the same person.
    anesthesiologists are not involved in the management of hemp medicines in principle.
    Encourage pharmacists to gradually integrate into the wards, operating rooms and other key departments of the hemp essence drug management team, to carry out the prescription of hemp essence medicine doctor's order review, prescription review, participate in the management of leprosy drugs, the use of the link of the check and double sign work.
    who participate in a double sign should avoid a permanent role as a permanent person.
    medical institutions shall formulate a two-person rotation management method and clarify the rotation cycle.
    For unused injections and residual fluids in analgesic pumps, they are disposed of by a physician, pharmacist, or nurse under video surveillance and recorded on a case-by-case basis.
    , to meet the needs of clinically reasonable hemp essence drugs medical institutions should be in accordance with the clinical drug needs of this institution, in accordance with the provisions of the purchase of hemp essence drugs and maintain a reasonable inventory.
    physicians with the right to prescribe ephedrology drugs should make reasonable use of hemp medicines in accordance with clinical norms, guidelines for the clinical application of narcotic drugs and psychotic drugs, drug specifications, etc.
    prescribing hemp medicine to patients with pain, the patient should be evaluated for pain and the appropriate drug should be selected in accordance with the principle of three-step analgesic treatment.
    strengthen the standardized treatment of cancer pain, acute pain and moderate and severe pain, rational use of hemp essence drugs, improve the quality of life of patients, avoid excessive control of hemp essence drugs affect patients' reasonable drug needs.
    medical institutions should organize special reviews on prescriptions of hemp essence drugs and in-patient doctor's orders, and intervene in a timely and effective manner according to the results of the reviews.
    pharmaceutical departments to monitor the use of the agency's leprosy drugs, for the abnormally high use of the agency's ephedrology drug management agency, analysis of the reasons and make management recommendations.
    6. To improve the level of information management of hemp essence drugs medical institutions should increase the input of hemp essence drug management hardware and software, relying on the modern hospital logistics system and information platform, strengthen the whole process management of hemp essence drugs, to achieve the source can be traced, go to traceable, responsibility can be investigated the whole closed-loop traceability management.
    areas where electronic seal card management has been implemented, we should continue to do a good job in the relevant work, and in areas that have not yet been implemented, we should speed up the construction of information technology and realize the information management of seal card as soon as possible.
    Conditional areas or medical institutions should actively explore the use of intelligent storage cabinets, electronic medicine cabinets and other intelligent equipment, combined with the actual development of hemp essence drug intelligent management system, and gradually achieve fine management, improve work efficiency and error prevention capabilities.
    7. Strengthen supervision and guidance and accountability the administrative departments of health and health at all levels to establish a long-term working mechanism, regularly carry out on-site guidance and inspection of hemp essence drugs in medical institutions, and take the management of hemp essence drugs as an important part of the work of medical institutions grade assessment, rational drug use assessment and so on.
    medical institutions should strengthen the relevant laws and regulations of medical personnel, reasonable drug use knowledge training, formulate and improve specific management systems, at least every six months to carry out special self-examination work, timely detection of problems and rectification and implementation.
    When a medical institution steals, loses, cheats, fraudulently takes or otherly enters an illegal channel, it shall immediately take control measures and immediately report them to the local county-level public security organs, drug supervision and administration departments and health administrative departments.
    If the implementation of the relevant policies is not in place, there are major security risks or the illegal flow of hemp essence drugs is caused by neglect of management, the relevant administrative departments, medical institutions and related personnel shall be seriously investigated for their responsibilities in accordance with the law;
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.